Lung Cancer Diagnosis and Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 101 pages | ID: L88CB3235FBFEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Lung Cancer Diagnosis and Therapeutics in Global, including the following market information:

Global Lung Cancer Diagnosis and Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Lung Cancer Diagnosis and Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Non-Small Cell Lung Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lung Cancer Diagnosis and Therapeutics include AstraZeneca, Eli Lilly, Sanofi, ArQule, Daiichi Sankyo, Celgene, Merck, Pfizer and Boehringer Ingelheim, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lung Cancer Diagnosis and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lung Cancer Diagnosis and Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lung Cancer Diagnosis and Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Non-Small Cell Lung Cancer
• Small Cell Lung Cancer

Global Lung Cancer Diagnosis and Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lung Cancer Diagnosis and Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Cancer Research Centers

Global Lung Cancer Diagnosis and Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lung Cancer Diagnosis and Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lung Cancer Diagnosis and Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Lung Cancer Diagnosis and Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Eli Lilly
• Sanofi
• ArQule
• Daiichi Sankyo
• Celgene
• Merck
• Pfizer
• Boehringer Ingelheim
• Roche
• Genentech
• GSK
• Pharmacyclics
• Novartis
• Bayer
• Bristol-Myers Squibb
• Eisai
• AbbVie

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Lung Cancer Diagnosis and Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Lung Cancer Diagnosis and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LUNG CANCER DIAGNOSIS AND THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Lung Cancer Diagnosis and Therapeutics Market Size: 2021 VS 2028
2.2 Global Lung Cancer Diagnosis and Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Lung Cancer Diagnosis and Therapeutics Players in Global Market
3.2 Top Global Lung Cancer Diagnosis and Therapeutics Companies Ranked by Revenue
3.3 Global Lung Cancer Diagnosis and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Diagnosis and Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lung Cancer Diagnosis and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Diagnosis and Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Lung Cancer Diagnosis and Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Diagnosis and Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Lung Cancer Diagnosis and Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Non-Small Cell Lung Cancer
  4.1.3 Small Cell Lung Cancer
4.2 By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Lung Cancer Diagnosis and Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Cancer Research Centers
5.2 By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Lung Cancer Diagnosis and Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Lung Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.3.2 US Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.3.3 Canada Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Lung Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.4.2 Germany Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.3 France Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.5 Italy Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.6 Russia Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Lung Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.5.2 China Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.3 Japan Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.6 India Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Lung Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.7.3 Israel Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.7.5 UAE Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.1.4 AstraZeneca Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 Eli Lilly
  7.2.1 Eli Lilly Corporate Summary
  7.2.2 Eli Lilly Business Overview
  7.2.3 Eli Lilly Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.2.4 Eli Lilly Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Eli Lilly Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.3.4 Sanofi Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Sanofi Key News
7.4 ArQule
  7.4.1 ArQule Corporate Summary
  7.4.2 ArQule Business Overview
  7.4.3 ArQule Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.4.4 ArQule Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 ArQule Key News
7.5 Daiichi Sankyo
  7.5.1 Daiichi Sankyo Corporate Summary
  7.5.2 Daiichi Sankyo Business Overview
  7.5.3 Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.5.4 Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Daiichi Sankyo Key News
7.6 Celgene
  7.6.1 Celgene Corporate Summary
  7.6.2 Celgene Business Overview
  7.6.3 Celgene Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.6.4 Celgene Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Celgene Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.7.4 Merck Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Merck Key News
7.8 Pfizer
  7.8.1 Pfizer Corporate Summary
  7.8.2 Pfizer Business Overview
  7.8.3 Pfizer Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.8.4 Pfizer Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Key News
7.9 Boehringer Ingelheim
  7.9.1 Boehringer Ingelheim Corporate Summary
  7.9.2 Boehringer Ingelheim Business Overview
  7.9.3 Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.9.4 Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Boehringer Ingelheim Key News
7.10 Roche
  7.10.1 Roche Corporate Summary
  7.10.2 Roche Business Overview
  7.10.3 Roche Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.10.4 Roche Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Roche Key News
7.11 Genentech
  7.11.1 Genentech Corporate Summary
  7.11.2 Genentech Business Overview
  7.11.3 Genentech Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.11.4 Genentech Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Genentech Key News
7.12 GSK
  7.12.1 GSK Corporate Summary
  7.12.2 GSK Business Overview
  7.12.3 GSK Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.12.4 GSK Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 GSK Key News
7.13 Pharmacyclics
  7.13.1 Pharmacyclics Corporate Summary
  7.13.2 Pharmacyclics Business Overview
  7.13.3 Pharmacyclics Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.13.4 Pharmacyclics Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.13.5 Pharmacyclics Key News
7.14 Novartis
  7.14.1 Novartis Corporate Summary
  7.14.2 Novartis Business Overview
  7.14.3 Novartis Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.14.4 Novartis Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.14.5 Novartis Key News
7.15 Bayer
  7.15.1 Bayer Corporate Summary
  7.15.2 Bayer Business Overview
  7.15.3 Bayer Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.15.4 Bayer Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.15.5 Bayer Key News
7.16 Bristol-Myers Squibb
  7.16.1 Bristol-Myers Squibb Corporate Summary
  7.16.2 Bristol-Myers Squibb Business Overview
  7.16.3 Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.16.4 Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.16.5 Bristol-Myers Squibb Key News
7.17 Eisai
  7.17.1 Eisai Corporate Summary
  7.17.2 Eisai Business Overview
  7.17.3 Eisai Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.17.4 Eisai Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.17.5 Eisai Key News
7.18 AbbVie
  7.18.1 AbbVie Corporate Summary
  7.18.2 AbbVie Business Overview
  7.18.3 AbbVie Lung Cancer Diagnosis and Therapeutics Major Product Offerings
  7.18.4 AbbVie Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.18.5 AbbVie Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Lung Cancer Diagnosis and Therapeutics Market Opportunities & Trends in Global Market
Table 2. Lung Cancer Diagnosis and Therapeutics Market Drivers in Global Market
Table 3. Lung Cancer Diagnosis and Therapeutics Market Restraints in Global Market
Table 4. Key Players of Lung Cancer Diagnosis and Therapeutics in Global Market
Table 5. Top Lung Cancer Diagnosis and Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lung Cancer Diagnosis and Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lung Cancer Diagnosis and Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lung Cancer Diagnosis and Therapeutics Product Type
Table 9. List of Global Tier 1 Lung Cancer Diagnosis and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Diagnosis and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lung Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lung Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lung Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lung Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 32. AstraZeneca Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Eli Lilly Corporate Summary
Table 34. Eli Lilly Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 35. Eli Lilly Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 38. Sanofi Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. ArQule Corporate Summary
Table 40. ArQule Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 41. ArQule Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Daiichi Sankyo Corporate Summary
Table 43. Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 44. Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Celgene Corporate Summary
Table 46. Celgene Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 47. Celgene Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 50. Merck Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 53. Pfizer Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Boehringer Ingelheim Corporate Summary
Table 55. Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 56. Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Roche Corporate Summary
Table 58. Roche Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 59. Roche Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Genentech Corporate Summary
Table 61. Genentech Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 62. Genentech Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. GSK Corporate Summary
Table 64. GSK Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 65. GSK Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. Pharmacyclics Corporate Summary
Table 67. Pharmacyclics Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 68. Pharmacyclics Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 69. Novartis Corporate Summary
Table 70. Novartis Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 71. Novartis Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 72. Bayer Corporate Summary
Table 73. Bayer Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 74. Bayer Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 75. Bristol-Myers Squibb Corporate Summary
Table 76. Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 77. Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 78. Eisai Corporate Summary
Table 79. Eisai Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 80. Eisai Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 81. AbbVie Corporate Summary
Table 82. AbbVie Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 83. AbbVie Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Lung Cancer Diagnosis and Therapeutics Segment by Type in 2021
Figure 2. Lung Cancer Diagnosis and Therapeutics Segment by Application in 2021
Figure 3. Global Lung Cancer Diagnosis and Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Diagnosis and Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lung Cancer Diagnosis and Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lung Cancer Diagnosis and Therapeutics Revenue in 2021
Figure 8. By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eli Lilly Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. ArQule Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Celgene Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Roche Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Genentech Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. GSK Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Pharmacyclics Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Novartis Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Bayer Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Eisai Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. AbbVie Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)